Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA.
Cell. 2011 Nov 11;147(4):853-67. doi: 10.1016/j.cell.2011.10.022.
Deciphering the signaling networks that underlie normal and disease processes remains a major challenge. Here, we report the discovery of signaling components involved in the Toll-like receptor (TLR) response of immune dendritic cells (DCs), including a previously unkown pathway shared across mammalian antiviral responses. By combining transcriptional profiling, genetic and small-molecule perturbations, and phosphoproteomics, we uncover 35 signaling regulators, including 16 known regulators, involved in TLR signaling. In particular, we find that Polo-like kinases (Plk) 2 and 4 are essential components of antiviral pathways in vitro and in vivo and activate a signaling branch involving a dozen proteins, among which is Tnfaip2, a gene associated with autoimmune diseases but whose role was unknown. Our study illustrates the power of combining systematic measurements and perturbations to elucidate complex signaling circuits and discover potential therapeutic targets.
破译正常和疾病过程中信号网络仍然是一个主要挑战。在这里,我们报告了在免疫树突状细胞(DC)的 Toll 样受体(TLR)反应中涉及的信号成分的发现,包括在哺乳动物抗病毒反应中共享的一个先前未知的途径。通过结合转录谱分析、遗传和小分子干扰以及磷酸蛋白质组学,我们发现了 35 个信号调节剂,包括 16 个已知的调节剂,它们参与 TLR 信号。特别是,我们发现 Polo 样激酶(Plk)2 和 4 是体外和体内抗病毒途径的必需组成部分,并激活了一个涉及十几个蛋白质的信号分支,其中包括 Tnfaip2,这是一个与自身免疫性疾病相关的基因,但它的作用尚不清楚。我们的研究说明了结合系统测量和干扰来阐明复杂的信号通路和发现潜在治疗靶点的力量。
Immunity. 2005-7
Proc Natl Acad Sci U S A. 2011-9-23
Uirusu. 2004-6
J Am Soc Nephrol. 2025-7-2
Nat Nanotechnol. 2024-8
J Clin Invest. 2023-11-1
Annu Rev Immunol. 2011
Nat Chem Biol. 2010-11-14
Nat Rev Drug Discov. 2010-8
Mol Syst Biol. 2010-6-8
Mol Biol Cell. 2010-5-19
Nat Rev Drug Discov. 2010-4
Immunity. 2010-3-26